title: A survey of antiprion compounds reveals the prevalence of non-PrP molecular targets.
abstract: Prion diseases are fatal neurodegenerative diseases caused by the accumulation of the misfolded isoform (PrP(Sc)) of the prion protein (PrP(C)). Cell-based screens have identified several compounds that induce a reduction in PrP(Sc) levels in infected cultured cells. However, the molecular targets of most antiprion compounds remain unknown. We undertook a large-scale, unbiased, cell-based screen for antiprion compounds and then investigated whether a representative subset of the active molecules had measurable affinity for PrP, increased the susceptibility of PrP(Sc) to proteolysis, or altered the cellular localization or expression level of PrP(C). None of the antiprion compounds showed in vitro affinity for PrP or had the ability to disaggregate PrP(Sc) in infected brain homogenates. These observations suggest that most antiprion compounds identified in cell-based screens deploy their activity via non-PrP targets in the cell. Our findings indicate that in comparison to PrP conformers themselves, proteins that play auxiliary roles in prion propagation may be more effective targets for future drug discovery efforts.
authors: Department of Neurology, University of California, San Francisco, California 94143, USA.
authors: Guillaume
authors: G
authors: Poncet-Montange
authors: Susan J
authors: SJ
authors: St Martin
authors: Olga V
authors: OV
authors: Bogatova
authors: Stanley B
authors: SB
authors: Prusiner
authors: Brian K
authors: BK
authors: Shoichet
authors: Sina
authors: S
authors: Ghaemmaghami
references: J Biomol Screen. 1999;4(2):67-73
references: 10838414
references: Annu Rev Med. 1987;38:381-98
references: 3555303
references: N Engl J Med. 2001 May 17;344(20):1516-26
references: 11357156
references: J Cell Sci. 2005 Nov 1;118(Pt 21):4959-73
references: 16219680
references: Nat Protoc. 2007;2(9):2212-21
references: 17853878
references: Cell. 1993 Jul 2;73(7):1339-47
references: 8100741
references: J Gen Virol. 2005 Oct;86(Pt 10):2913-2923
references: 16186247
references: J Immunol Methods. 1994 Jun 24;172(2):227-39
references: 7518485
references: J Virol. 2000 May;74(9):4377-86
references: 10756052
references: Proc Natl Acad Sci U S A. 2007 Nov 13;104(46):17971-6
references: 17989223
references: Science. 2004 Jul 30;305(5684):673-6
references: 15286374
references: PLoS Pathog. 2009 Nov;5(11):e1000666
references: 19936054
references: Proc Natl Acad Sci U S A. 2010 Oct 12;107(41):17610-5
references: 20876144
references: Proc Natl Acad Sci U S A. 2001 Aug 14;98(17):9836-41
references: 11504948
references: J Am Chem Soc. 2010 Feb 3;132(4):1359-70
references: 20043671
references: Biochemistry. 2005 Apr 5;44(13):5258-66
references: 15794662
references: Biochemistry. 1995 Jul 11;34(27):8564-75
references: 7612598
references: J Gen Virol. 2009 May;90(Pt 5):1294-1301
references: 19264641
references: Science. 2003 Oct 31;302(5646):871-4
references: 14593181
references: EMBO J. 1996 Dec 2;15(23):6363-73
references: 8978663
references: J Biol Chem. 1997 May 23;272(21):13793-802
references: 9153235
references: Cell. 1986 Aug 1;46(3):417-28
references: 2873895
references: Neurosci Lett. 2005 Nov 11;388(2):106-11
references: 16039063
references: Trends Biochem Sci. 1999 Sep;24(9):329-32
references: 10470028
references: J Virol. 2010 Apr;84(7):3408-12
references: 20032192
references: Anal Biochem. 2004 Mar 1;326(1):125-7
references: 14769346
references: Nature. 1996 Jul 11;382(6587):180-2
references: 8700211
references: Biochemistry. 1983 Aug 2;22(16):3975-84
references: 6615812
references: Antimicrob Agents Chemother. 2007 Nov;51(11):3887-94
references: 17709470
references: J Virol. 2001 Apr;75(7):3453-61
references: 11238871
references: J Virol. 2003 Oct;77(19):10288-94
references: 12970413
references: J Virol. 1998 Nov;72(11):9413-8
references: 9765500
references: J Mol Biol. 1997 Oct 31;273(3):614-22
references: 9356250
references: J Mol Biol. 2002 Aug 9;321(2):285-96
references: 12144785
references: EMBO J. 2001 Aug 1;20(15):3957-66
references: 11483499
references: J Cell Biol. 1995 Apr;129(1):121-32
references: 7698979
references: J Struct Biol. 2010 Oct;172(1):107-19
references: 20466062
references: Nat Struct Biol. 2000 Apr;7(4):312-21
references: 10742177
references: Proc Natl Acad Sci U S A. 1997 Sep 16;94(19):10086-91
references: 9294167
references: Proc Natl Acad Sci U S A. 2000 May 23;97(11):6073-8
references: 10823951
references: Curr Opin Struct Biol. 2000 Feb;10(1):60-8
references: 10679462
references: J Pharmacol Toxicol Methods. 2000 Jul-Aug;44(1):235-49
references: 11274893
references: Proc Natl Acad Sci U S A. 2003 Mar 18;100(6):3416-21
references: 12626750
references: Biochemistry. 1996 Apr 30;35(17):5528-37
references: 8611544
references: Proc Natl Acad Sci U S A. 1997 Dec 9;94(25):13452-7
references: 9391046
references: J Med Chem. 2003 Aug 14;46(17):3563-4
references: 12904059
references: Mol Cell Neurosci. 2006 Feb;31(2):346-53
references: 16278084
references: J Gen Virol. 1987 May;68 ( Pt 5):1391-9
references: 3106566
references: J Virol. 1988 May;62(5):1558-64
references: 3282080
references: J Mol Biol. 2004 Mar 5;336(5):1175-83
references: 15037077
references: Brain. 2006 Sep;129(Pt 9):2241-65
references: 16816391
references: Nat Struct Biol. 2001 Sep;8(9):770-4
references: 11524679
references: Proc Natl Acad Sci U S A. 1999 Dec 7;96(25):14529-34
references: 10588739